Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Zihipp Logo
Zihipp Growth Score
31
CB Rank
118512
Heat Score
40
Zihipp is a healthcare company that assists in losing weight and treating weight gain caused by diabetes.
Founded
obfuscation
PrivateSeries A London, England, United Kingdom1-10 www.zihipp.com/
Health Care
Overview

Zihipp
Total Funding
obfuscation
Growth Score
31
Heat Score
40

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score31
-3 pts
in past quarter
Heat Score 40
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Zihipp

CB Rank
118512
Zihipp is a healthcare company that assists in losing weight and treating weight gain caused by diabetes.
Founded
obfuscation
PrivateSeries A London, England, United Kingdom1-10 www.zihipp.com/
Health Care

Funding Rounds

Series A
OBF
in
obfuscation

Key People

  • Photo of Dunstan Cooke
    Dunstan Cooke: Director Corporate Operations
    Past Role: Plaxica, Business Director

Details

Legal Name Zihipp Limited
Operating Status Active
Company Type For Profit
About the Company
Zihipp is a biotechnology company. They offer services that include weight loss therapies for the treatment of obesity and diabetes. They offer services for women, adults, and men.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Satiety hormone analogues
Zihipp is developing satiety hormone analogues, including oxyntomodulin, GLP-1, GIP, and PYY analogues, optimized for potency and extended half-lives for obesity and diabetes treatment.
Combination treatments
Combination treatments administered as single injections for obesity and diabetes, allowing dosing adjustments to balance weight loss and carbohydrate tolerance improvement.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A
obfuscation
Series A - Zihipp Logo
Series A - Zihipp
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Nov 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$45.7KThis year, Zihipp is projected to spend $45.7K on IT, according to Aberdeen.

Active Website Tech Count

2
Sub-Organizations
Frequently Asked Questions

Where is Zihipp's headquarters? Zihipp is located in London, England, United Kingdom.When was the last funding round for Zihipp? Zihipp closed its last funding round on
obfuscation
from a Series A round.Who are Zihipp's competitors? Alternatives and possible competitors to Zihipp may include Eli Lilly, BioAge Labs, and  Novo Nordisk.How much funding has Zihipp raised to date? Zihipp has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|